For 43 years, Fahad Al Hashimi’s existence was tethered to a rigid medical schedule. Living with thalassemia, an inherited blood disorder, meant he required blood transfusions every three weeks and daily iron-chelation therapy to manage his health. His energy levels were a constant rollercoaster; while a transfusion would briefly invigorate him, he would inevitably succumb to extreme exhaustion as his haemoglobin levels dipped, forcing him to plan his professional life, family time, and travel around his next hospital visit. Despite his resilience, the physical and emotional burden of the illness—marked by needles, pumps, and the frustration of constant limitations—felt like an unavoidable reality.

The turning point came when Fahad discovered gene therapy using CRISPR technology, an advanced medical breakthrough that offered a path beyond the unsuccessful search for a bone marrow donor. Despite the grueling nature of the treatment, which involved chemotherapy and weeks of hospital isolation to reset his system with his own genetically modified stem cells, the outcome was life-altering. Today, Fahad no longer relies on transfusions and enjoys the freedom to travel, exercise, and live spontaneously. His journey serves as a powerful testament to the rapid advancements in medical science, offering newfound hope to others battling chronic conditions that they, too, might one day reclaim their autonomy.